Delivery Order SPE2DR25D2006-SPE2DR26F56NK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,370.46 to AmerisourceBergen Drug Corp for the supply of Spravato 84 mg dose pack UDS (unit dose system). This firm fixed-price delivery order, awarded on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract place of performance is AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,005.06 firm fixed-price delivery order is for the supply of SPRAVATO 84 MG DOSE PACK medical product, with an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division to provide SPRAVATO 84 MG DOSE PACK UDS, a pharmaceutical product, for a firm fixed price of $4,959.80. This contract has an ultimate completion date of June 25, 2024. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, fulfills this delivery order as part of a larger Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,842.58 firm fixed price delivery order is for the supply of SPRAVATO 84 MG DOSE PACK UDS, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide SPRAVATO 84 MG DOSE PACK UDS, a pharmaceutical product, for a potential value of $8,484.59. The contract has a completion date of March 6, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA to supply a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of SPRAVATO 84 MG DOSE PACK UDS. The firm fixed price contract has a potential value of $14,978.16 and a completion date of December 26, 2023. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. The contract does not...
- This federal contract award, valued at $13,927.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, is for the provision of SPRAVATO 84 MG DOSE PACK UDS, a specialty medication. The contract has no set-aside designation, indicating open competition. This IDC, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $15,328.09 firm fixed-price delivery order is for the supply of SPRAVATO 84 MG DOSE PACK UDS, a pharmaceutical product, with a period of performance through February 22, 2024. The award was not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SPRAVATO 84 MG DOSE PACK UDS, a medical product, with a ceiling value of $8,812.72. The contract is a firm-fixed price delivery order with a completion date of June 9, 2025. This award is not associated with a set-aside program, indicating open competition. AmerisourceBergen Drug Corp...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $25,272.36 for the supply of Esketamine 3x28GM 3S under a firm fixed-price contract. The award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a non-set-aside competitive procurement by the Defense Logistics Agency's Medical Supply Chain division. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56NKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,336.81 to AmerisourceBergen Drug Corp for the supply of Spravato 84 mg dose pack UDS (unit dose system). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 8, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as a critical pharmaceutical distributor for federal medical procurement needs. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX contract running through December 2026), which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. Spravato (esketamine) is a specialized neurological/psychiatric medication used in treatment-resistant depression, reflecting the company's extensive portfolio of specialty pharmaceuticals across multiple therapeutic domains. AmerisourceBergen's federal contract awards demonstrate its capability to compete successfully in open contracting for complex medical supply requirements serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 12/4/25 |